1. Home
  2. CFFN vs MNKD Comparison

CFFN vs MNKD Comparison

Compare CFFN & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capitol Federal Financial Inc.

CFFN

Capitol Federal Financial Inc.

HOLD

Current Price

$7.79

Market Cap

981.1M

Sector

Finance

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.39

Market Cap

877.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFN
MNKD
Founded
1893
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
981.1M
877.0M
IPO Year
2010
2004

Fundamental Metrics

Financial Performance
Metric
CFFN
MNKD
Price
$7.79
$3.39
Analyst Decision
Hold
Buy
Analyst Count
2
8
Target Price
$7.25
$8.69
AVG Volume (30 Days)
858.4K
5.6M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
4.51%
N/A
EPS Growth
79.31
N/A
EPS
0.32
N/A
Revenue
$16,300,000.00
$348,966,000.00
Revenue This Year
$20.16
$35.81
Revenue Next Year
$6.62
$11.89
P/E Ratio
$24.25
N/A
Revenue Growth
6.54
22.23
52 Week Low
$5.51
$2.23
52 Week High
$7.97
$6.51

Technical Indicators

Market Signals
Indicator
CFFN
MNKD
Relative Strength Index (RSI) 56.60 64.76
Support Level $7.47 $3.39
Resistance Level $7.84 $6.08
Average True Range (ATR) 0.17 0.22
MACD -0.01 0.10
Stochastic Oscillator 60.22 47.06

Price Performance

Historical Comparison
CFFN
MNKD

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: